Pancreatic Polypeptide (31-36) (human)
CAS No. 74012-13-8
Pancreatic Polypeptide (31-36) (human)( ——— )
Catalog No. M41492 CAS No. 74012-13-8
Pancreatic Polypeptide (31-36) (human)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePancreatic Polypeptide (31-36) (human)
-
NoteResearch use only, not for human use.
-
Brief DescriptionPancreatic Polypeptide (31-36) (human)
-
DescriptionPancreatic Polypeptide (31-36) (human)
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number74012-13-8
-
Formula Weight804
-
Molecular FormulaC36H61N13O8
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Caspase 3 Substrate,...
Caspase 3 Substrate, chromogenic; Ac-VQVD-pNA
-
[Pyr1]-Apelin-13
[Pyr1]-Apelin-13 is a potent and selective endogenous Apelin receptor (APJ) agonist.[Pyr1]-apelin-13 encapsulation in lipoPEG particles (lipoPEG-PA13) results in sustained and extended drug release under physiological conditions[1].[Pyr1]-apelin-13 nanocarriers in a mouse model of pressure-overload induced heart failure demonstrate a sustainable long-term effect of [Pyr1]-apelin-13 in preventing cardiac dysfunction.
-
Polysorbate 20
Polysorbate 20 (Tween-20) ,sorbitan mono-9-octadecanoate poly(oxy-1,2-ethanediyl) derivatives, is used in the formulation of biotherapeutic products for both preventing surface adsorption and as a stabilizer against protein aggregation.
Cart
sales@molnova.com